Induction of Sympathetic Ophthalmia Following Vitrectomy for Endogenous Fungal Endophthalmitis
Background
Sympathetic ophthalmia is a rare but serious bilateral granulomatous uveitis that can occur after ocular trauma or intraocular surgery. The condition poses significant risks to vision and is characterized by a complex immune response to ocular antigens.
Data Highlights
No numerical data or trial data provided in the article.
Key Findings
A 22-year-old male developed sympathetic ophthalmia after two vitrectomy procedures for fungal endophthalmitis.
The causative organism was identified as Aspergillus flavus.
Initial visual acuity was 0.8 in the right eye and 0.02 in the left eye at presentation.
Multimodal imaging confirmed the diagnosis of sympathetic ophthalmia.
Treatment with prednisone and adalimumab stabilized the patient's condition over a 13-month follow-up.
No recurrences of sympathetic ophthalmia were observed during the follow-up period.
Clinical Implications
Early diagnosis and aggressive treatment strategies are essential for managing sympathetic ophthalmia, particularly following intraocular surgeries. Clinicians should maintain a high index of suspicion for SO in patients with a history of ocular trauma or surgery, especially when presenting with visual disturbances.
Conclusion
This case highlights the development of sympathetic ophthalmia following vitrectomy for fungal endophthalmitis.
For ASCs seeking long-term stability, panelists at the OOSS symposium agreed that success will depend on understanding the full range of anesthesia delivery models and choosing the approach that best aligns with each organization’s goals and resources.
